当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Kidney Safety Assessment: Current Drug Development Techniques

Carmela N Keichel

The kidney’s position as a main route of metabolism and clearance of xenobiotics and its potential to listen the glomerular filtrate make it especially prone to drug-induced toxicity. Improving kidney protection is a lively place of lookup and there is a want in early levels of drug improvement for techniques and mannequin structures to reliably discover nephrotoxic compounds and sufficiently represent mechanisms to aid drug pipeline selection making. In later tiers of drug improvement the fee of touchy translational biomarkers to display kidney toxicity throughout species in nonclinical and scientific settings is gaining realization. Various equipment and techniques for kidney security evaluation have emerged over the previous decade; however, there is presently no clear consensus on great practices for their use throughout exclusive phases of drug development. Here, we furnish standpoint on the scope of this hassle in drug development, and an overview of growth in the discipline of kidney security which includes numerous informative case examples of kidney toxicity de-risking eventualities encountered in the pharmaceutical industry. The outcomes of a survey of pharmaceutical agencies performed thru the Innovation and Quality Drug Safety consortium presents extra perception into current experiences with compound attrition and distinctive de-risking methods throughout the industry.